Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Geospiza and SAIC-Frederick Collaborate to Accelerate Cancer Research with PacBio RS

Abstract:
Geospiza and Maryland-based SAIC-Frederick Inc. are collaborating to adapt Geospiza's software platform to a new generation of rapid, high-resolution gene sequencing technology to potentially accelerate cancer research and help develop new treatments.

Geospiza and SAIC-Frederick Collaborate to Accelerate Cancer Research with PacBio RS

Seattle | Posted on August 31st, 2010

SAIC-Frederick is an early adopter of cutting-edge, third-generation sequencing technology designed to provide faster, high-resolution DNA sequences for use in cancer research. The newest second generation gene sequencers can rapidly produce huge amounts of genetic data, in some cases approaching 3 billion sequences - the equivalent of an entire human genome - in just two days. This advance holds great promise for advancing scientists' understanding of the genetic basis of cancer. It also presents new challenges, especially in regard to managing unprecedented volumes of data and accurately correlating them with patient information.

Geospiza and SAIC-Frederick are collaborating to address these challenges by integrating Geospiza's GeneSifter Lab Edition product for data acquisition and analysis with a third-generation sequencer, PacBio RS, Pacific Biosciences' Single Molecule Real Time (SMRT™) biological detection platform.

SAIC-Frederick will use GeneSifter interfaces already in place in its labs to create custom workflows and data analysis unique to SMRT sequencing. SAIC-Frederick will also provide enhancements for systems analysis and for automation. The result will provide researchers with a productive data management system tailored to their needs.

Having in place a rapid, third-generation sequencing system is expected to accelerate studies into the genetic basis of cancer and to pave the way for more effective treatments. SAIC-Frederick, a contractor for the National Cancer Institute's laboratories in Frederick, Md., is facilitating the collaboration as part of NCI's Advanced Technology Partnerships Initiative, which seeks to reduce the time and cost of developing new cancer treatments.

####

About Geospiza
SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation, is the operations and technical support contractor for the National Cancer Institute's research and development center in Frederick, Md. This national laboratory is dedicated to rapidly translating basic research into new technologies for diagnosing, treating, and preventing cancer and AIDS. SAIC-Frederick maintains a full suite of advanced technologies in areas such as nanotechnology, genomics and imaging; operates the federal government's drug and vaccine manufacturing facilities; operates the high-performance Advanced Biomedical Computing Center; and supports more than 300 clinical trials for patients in the United States and around the world.

Information about the NCI's Advanced Technology Partnerships Initiative is at ATPIhome.com

About Geospiza
Designed by biologists, Geospiza's products are configured to reflect best practices and to work out-of-the-box, so that researchers can focus on their science. Geospiza's software systems have established an international reputation for usability and performance since 1997. You can find more information on Geospiza and its products at www.geospiza.com.

For more information, please click here

Contacts:
Geospiza, Inc.
Dale Baskin
206-633-4403 x170


SAIC-Frederick, Inc.
Frank Blanchard
301-846-1893

Copyright © Geospiza

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

ANU invention to inspire new night-vision specs December 7th, 2016

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

Software

Companies Now Can Bring Fast and Accurate Nanoparticle Analysis In-House November 11th, 2016

SUN shares its latest achievements during the 3rd Annual Project Meeting November 1st, 2016

Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016

Park Systems Launches Park NX20 300mm Research Atomic Force Microscope with Full 300 mm Semiconductor Wafer Scan - Vastly Improving Productivity August 3rd, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

ANU invention to inspire new night-vision specs December 7th, 2016

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

Alliances/Trade associations/Partnerships/Distributorships

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

Mechanism for sodium storage in 2-D material: Tin selenide is an effective host for storing sodium ions, making it a promising material for sodium ion batteries October 27th, 2016

Enterprise In Space Partners with Sketchfab and 3D Hubs for NewSpace Education October 13th, 2016

Research partnerships

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Quantum obstacle course changes material from superconductor to insulator December 1st, 2016

Novel silicon etching technique crafts 3-D gradient refractive index micro-optics November 28th, 2016

Single photon converter -- a key component of quantum internet November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project